isosorbide dinitrate has been researched along with natriuretic peptide, brain in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (66.67) | 29.6817 |
2010's | 3 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gottsäter, A; Ohlin, AK; Ohlin, H; Tingberg, E | 1 |
Atar, D; Hodt, A; Steine, K | 1 |
Ohlin, H; Roijer, A; Thilen, U; Tingberg, E | 1 |
Adams, K; Carson, P; Cohn, JN; Ferdinand, K; Ofili, E; Olukotun, AY; Sabolinski, ML; Tam, SW; Taylor, AL; Taylor, M; Worcel, M; Yancy, CW; Ziesche, S | 1 |
Anand, IS; Cohn, JN; Sabolinski, ML; Tam, SW; Taylor, AL; Worcel, M | 1 |
Dries, DL; McNamara, D; Rame, JE; Sabolinski, ML; Tam, SW; Worcel, M; Wu, AH | 1 |
Pan, X; Yu, X; Zhang, J; Zhao, G | 1 |
Anstrom, KJ; Borlaug, BA; Braunwald, E; Chen, HH; Cole, RT; Felker, GM; Joseph, SM; Koepp, GA; Levine, JA; LeWinter, MM; McNulty, SE; Redfield, MM; Reeves, GR; Semigran, MJ; Shah, MR; Shah, SJ; Tang, WH; Tedford, RJ; Velazquez, EJ | 1 |
Butler, J; Felker, GM; Patel, RB; Redfield, MM; Shah, SJ; Vaduganathan, M | 1 |
1 review(s) available for isosorbide dinitrate and natriuretic peptide, brain
Article | Year |
---|---|
[Medical and ventilatory treatment of acute heart failure].
Topics: Acute Disease; Adrenergic beta-Agonists; Cardiotonic Agents; Continuous Positive Airway Pressure; Diuretics; Dobutamine; Furosemide; Heart Failure; Humans; Hydrazones; Isosorbide Dinitrate; Natriuretic Agents; Natriuretic Peptide, Brain; Nitric Oxide Donors; Oxygen Inhalation Therapy; Practice Guidelines as Topic; Pyridazines; Simendan; Vasodilator Agents | 2006 |
7 trial(s) available for isosorbide dinitrate and natriuretic peptide, brain
Article | Year |
---|---|
Lipid peroxidation is not increased in heart failure patients on modern pharmacological therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Captopril; Comorbidity; Delayed-Action Preparations; Dinoprost; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Lipid Peroxidation; Losartan; Male; Malondialdehyde; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Nitric Oxide Donors; Oxidative Stress; Ramipril; Stroke Volume; Ultrasonography; Ventricular Dysfunction, Left | 2006 |
Neurohumoral changes in patients with left ventricular dysfunction following acute myocardial infarction and the effect of nitrate therapy: a randomized, double-blind, placebo-controlled long-term study.
Topics: Adult; Aged; Aldosterone; Atrial Natriuretic Factor; Double-Blind Method; Echocardiography; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Norepinephrine; Renin; Substance P; Ventricular Dysfunction, Left | 2006 |
Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure Trial.
Topics: Adult; Aged; Arthralgia; Biomarkers; Black or African American; Cardiovascular Agents; Cause of Death; Disease-Free Survival; Dizziness; Double-Blind Method; Drug Combinations; Heart Failure; Heart Transplantation; Hospitalization; Humans; Hydralazine; Hypotension; Isosorbide Dinitrate; Kaplan-Meier Estimate; Middle Aged; Mortality; Natriuretic Peptide, Brain; Nitric Oxide Donors; Proportional Hazards Models; Quality of Life; Surveys and Questionnaires; Treatment Outcome; Vasodilator Agents | 2007 |
Isosorbide dinitrate and hydralazine in a fixed-dose combination produces further regression of left ventricular remodeling in a well-treated black population with heart failure: results from A-HeFT.
Topics: Adult; Aged; Black or African American; Drug Therapy, Combination; Female; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Natriuretic Peptide, Brain; Stroke Volume; Treatment Outcome; Ultrasonography; Ventricular Remodeling | 2007 |
Intravenous diuretic and vasodilator therapy reduce plasma brain natriuretic peptide levels in acute exacerbation of chronic obstructive pulmonary disease.
Topics: Aged; Aminophylline; Bronchodilator Agents; Disease Progression; Drug Combinations; Female; Furosemide; Glucocorticoids; Health Status; Health Status Indicators; Humans; Infusions, Intravenous; Isosorbide Dinitrate; Male; Methylprednisolone; Middle Aged; Natriuretic Peptide, Brain; Pulmonary Disease, Chronic Obstructive; Quality of Life; Vasodilator Agents | 2012 |
Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction.
Topics: Accelerometry; Aged; Cross-Over Studies; Double-Blind Method; Exercise Tolerance; Female; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged; Motor Activity; Natriuretic Peptide, Brain; Peptide Fragments; Quality of Life; Stroke Volume; Vasodilator Agents; Walking | 2015 |
Physical Activity, Quality of Life, and Biomarkers in Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction (from the NEAT-HFpEF Trial).
Topics: Accelerometry; Aged; Aged, 80 and over; Atrial Fibrillation; Biomarkers; Cross-Over Studies; Double-Blind Method; Exercise; Exercise Tolerance; Female; Follow-Up Studies; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Prognosis; Protein Precursors; Quality of Life; Stroke Volume | 2019 |
1 other study(ies) available for isosorbide dinitrate and natriuretic peptide, brain
Article | Year |
---|---|
Dysfunctional corin i555(p568) allele is associated with impaired brain natriuretic peptide processing and adverse outcomes in blacks with systolic heart failure: results from the Genetic Risk Assessment in Heart Failure substudy.
Topics: Black or African American; Cardiovascular Agents; Double-Blind Method; Drug Combinations; Female; Gene Frequency; Genetic Predisposition to Disease; Heart Failure, Systolic; Hospitalization; Humans; Hydralazine; Immunoassay; Isosorbide Dinitrate; Kaplan-Meier Estimate; Male; Middle Aged; Multicenter Studies as Topic; Mutation; Natriuretic Peptide, Brain; Phenotype; Proportional Hazards Models; Protein Processing, Post-Translational; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Assessment; Risk Factors; Serine Endopeptidases; Treatment Outcome; United States | 2009 |